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Results: The phantom study showed that phantom position 
was linearly correlated with the exit detector measurements 
resulting in an r > 0.99. The standard deviation in the 
measured breast surface position, σ, was 2.28 mm for the 
453 analyzed detector fluences (σmin = 1.39 mm, σmax = 
4.33 mm). The uncertainty in the detector measurements 
was estimated to be under one detector channel’s width. 
 
Conclusion: The σ results of this study should be an indicator 
of the overall positioning uncertainty in our IGRT process for 
these treatments, i.e. kVCT-MVCT image registration, patient 
movement, and respiratory motion. Even if only one 
projection of the treatment data was used in the estimation, 
our results compare very well with similar studies’ (von 
Tienhoven et al (1991), Smith et al (2005), Wang et al (2013)) 
findings on breast displacement due to respiratory motion. 
Furthermore, the novelty of this study is its evaluation of the 
breast position was performed on exit detector fluence of 
intensity-modulated fields, which we believe to be a first. 
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Purpose or Objective: A a real-time patient treatment 
verification system using EPID (Watchdog) for clinical 
implementation was developed as an advanced patient safety 
tool. However to use Watchdog for treatment intervention 
we need to understand its response to clinically significant 
errors. The purpose of this study is to investigate the 
performance of Watchdog under controlled error conditions.  
 
Material and Methods: The real-time verification system 
(Watchdog) utilises a comprehensive physics-based model to 
generate a series of predicted transit cine EPID image as a 
reference data set, and compares these to measured cine-
EPID images acquired during treatment. The agreement 
between the predicted and measured transit images is 
quantified using chi-comparison on a cumulative frame basis.  
To determine the ability of Watchdog to detect clinically 
significant errors during treatment delivery we used real 
patient data and simulated dosimetric and patient positional 
errors. Four study cases were used; dosimetric error in 
Prostate IMRT, HN patient weight loss, prostate displacement 
and lung SBRT displacement errors. These errors were 
introduced by modifying the planning CT scan data and re-
calculating the predicted EPID data set. The error embedded 
predicted EPID data sets were compared to the measured 
EPID data acquired during patient treatment.  
 
Results: The average % cumulative chi pass-rate across four 
case studies were 84.0% and 94.5% for 3%, 3mm and 4%, 4mm 
respectively. In the figures, the cumulative chi pass-rate 
results based on error simulation are shown. The difference 
ratio of chi comparison criteria between 3%, 3mm and 4%, 
4mm was approximately 13%. As a result, the threshold level 
should determine based on the criteria and clinical acceptant 
limit. 
 
 
Conclusion: We have evaluated our proposed real-time EPID-
based treatment verification system using clinical relevant 
error simulation in prostate, HN and lung cases. Using either 
a 3%, 3mm or 4%, 4mm criteria, the real-time EPID-based 
patient verification system successfully detected simulated 
errors introduced into patient plan deliveries; including 5% 
dosimetric errors on prostate IMRT, 5mm prostate IMRT 
displacement, 5% HN patient weight loss, and 5mm Lung SBRT 
displacement.  
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Purpose or Objective: The increasing complexity of modern 
radiation therapy requires major quality control (QC) to 
ensure safety and reliability of patients’ treatments. The 
large number of QCs requires a considerable amount of work 
that sometime is responsible of missing controls that may 
lead to dosimetric errors. In this frame the in vivo dosimetry 
(IVD) by EPID images has an important role to detect eventual 
dosimetric discrepancies between planned and delivered 
doses. The present work reports the results of 7500 IVD tests 
obtained in the last 2 years in 7 Italian Centers. 
 
Material and Methods: SOFTDISO is an IVD-program 
distributed by the Best Medical Italy for 3D-CRT ,IMRT and 
